Back to search
FDAFDA · Food and drugs·Recall number D-0774-2016

Paricalcitol Capsules, 1 mcg, 30 tablets per Bottle, Rx Only, Manufactured By: Pharmaceutics International, Inc., Hunt Valley, MD 21031, Manufactured For: Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0093-7656-56.

Published March 23, 2016 · Recall initiated: February 5, 2016

Summary

FDA records drug Class II recall D-0774-2016, published March 23, 2016 and initiated February 5, 2016. Recalling firm: Teva Pharmaceuticals USA; Status: Terminated; Reported quantity: 30,891 Bottles; Lot: Lot #: 13013.009A, Exp. 02/2016. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: Out of specification test results for impurities during stability testing.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Teva Pharmaceuticals USA
Distributor
Nationwide and Puerto Rico
Lot
Lot #: 13013.009A, Exp. 02/2016
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Paricalcitol Capsules, 1 mcg, 30 tablets per Bottle, Rx Only, Manufactured By: Pharmaceutics International, Inc., Hunt Valley, MD 21031, Manufactured For: Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0093-7656-56. recalled?

Yes. FDA published recall D-0774-2016 on March 23, 2016. Reported hazard: Failed Impurities/Degradation Specifications: Out of specification test results for impurities during stability testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter